WO1997020937A3 - Modification process - Google Patents

Modification process Download PDF

Info

Publication number
WO1997020937A3
WO1997020937A3 PCT/EP1996/005581 EP9605581W WO9720937A3 WO 1997020937 A3 WO1997020937 A3 WO 1997020937A3 EP 9605581 W EP9605581 W EP 9605581W WO 9720937 A3 WO9720937 A3 WO 9720937A3
Authority
WO
WIPO (PCT)
Prior art keywords
modification process
mannose
galactose
containing compound
vivo modification
Prior art date
Application number
PCT/EP1996/005581
Other languages
French (fr)
Other versions
WO1997020937A2 (en
Inventor
Morten Joersboe
Janne Brunstedt
Steen Guldager Petersen
Original Assignee
Danisco
Morten Joersboe
Janne Brunstedt
Steen Guldager Petersen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danisco, Morten Joersboe, Janne Brunstedt, Steen Guldager Petersen filed Critical Danisco
Priority to AU11939/97A priority Critical patent/AU1193997A/en
Priority to EP96943105A priority patent/EP0866869A2/en
Priority to BR9612773-2A priority patent/BR9612773A/en
Priority to JP9521002A priority patent/JP2000502252A/en
Publication of WO1997020937A2 publication Critical patent/WO1997020937A2/en
Publication of WO1997020937A3 publication Critical patent/WO1997020937A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2408Glucanases acting on alpha -1,4-glucosidic bonds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0087Glucomannans or galactomannans; Tara or tara gum, i.e. D-mannose and D-galactose units, e.g. from Cesalpinia spinosa; Tamarind gum, i.e. D-galactose, D-glucose and D-xylose units, e.g. from Tamarindus indica; Gum Arabic, i.e. L-arabinose, L-rhamnose, D-galactose and D-glucuronic acid units, e.g. from Acacia Senegal or Acacia Seyal; Derivatives thereof
    • C08B37/0096Guar, guar gum, guar flour, guaran, i.e. (beta-1,4) linked D-mannose units in the main chain branched with D-galactose units in (alpha-1,6), e.g. from Cyamopsis Tetragonolobus; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8245Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)

Abstract

An in vivo modification process is described. The in vivo modification process affects the mannose-to-galactose ratio of either an organism (or part thereof) capable of producing a mannose/galactose containing compound or of a mannose/galactose containing compound thereof.
PCT/EP1996/005581 1995-12-04 1996-12-02 Modification process WO1997020937A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU11939/97A AU1193997A (en) 1995-12-04 1996-12-02 Modification process
EP96943105A EP0866869A2 (en) 1995-12-04 1996-12-02 Modification process
BR9612773-2A BR9612773A (en) 1995-12-04 1996-12-02 Modification process.
JP9521002A JP2000502252A (en) 1995-12-04 1996-12-02 Modification process

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9524752.4 1995-12-04
GBGB9524752.4A GB9524752D0 (en) 1995-12-04 1995-12-04 Modification process

Publications (2)

Publication Number Publication Date
WO1997020937A2 WO1997020937A2 (en) 1997-06-12
WO1997020937A3 true WO1997020937A3 (en) 1997-11-27

Family

ID=10784871

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1996/005581 WO1997020937A2 (en) 1995-12-04 1996-12-02 Modification process

Country Status (8)

Country Link
EP (1) EP0866869A2 (en)
JP (1) JP2000502252A (en)
CN (1) CN1207772A (en)
AU (1) AU1193997A (en)
BR (1) BR9612773A (en)
GB (1) GB9524752D0 (en)
MX (1) MX9804483A (en)
WO (1) WO1997020937A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6311808B1 (en) 1996-02-09 2001-11-06 Continental Teves Ag & Co., Ohg Combined service and parking brake system
GB9710990D0 (en) * 1997-05-28 1997-07-23 Danisco Modification process
GB9807520D0 (en) * 1998-04-09 1998-06-10 Univ Wales Medicine Modified biological material
GB9810997D0 (en) * 1998-05-21 1998-07-22 Unilever Plc Genes & enzymes
BR9915148A (en) * 1998-11-11 2001-08-07 Produites Nestle S A Soc D Arabic coffee mannase
EP1138771A1 (en) * 2000-03-30 2001-10-04 Societe Des Produits Nestle S.A. Coffee endo-mannanase
MXPA04004278A (en) * 2001-11-06 2004-08-11 Univ British Columbia Modulating urea degradation in wine yeast.
AU2003290793A1 (en) 2002-11-14 2004-06-15 Pioneer Hi-Bred International, Inc. Genes for galactomannan production in plants and methods of use
JP4960591B2 (en) * 2004-12-14 2012-06-27 味の素ゼネラルフーヅ株式会社 Anti-allergen composition containing mannooligosaccharides
US7678556B2 (en) 2006-11-21 2010-03-16 Cornell Research Foundation, Inc. Beta-mannanase from coffee berry borer, Hypothenemus hampei, and uses thereof
WO2008112170A1 (en) 2007-03-09 2008-09-18 Corning Incorporated Three dimensional gum matrices for cell culture, manufacturing methods and methods of use

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0192401A2 (en) * 1985-02-12 1986-08-27 Novo Nordisk A/S Polypeptide product
EP0255153A1 (en) * 1986-06-03 1988-02-03 Unilever N.V. Production of guar alpha-galactosidase by hosts transformed by recombinant DNA methods
WO1995007088A1 (en) * 1993-09-08 1995-03-16 New York Blood Center, Inc. RECOMBINANT α-GALACTOSIDASE ENZYME AND cDNA ENCODING SAID ENZYME

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0192401A2 (en) * 1985-02-12 1986-08-27 Novo Nordisk A/S Polypeptide product
EP0255153A1 (en) * 1986-06-03 1988-02-03 Unilever N.V. Production of guar alpha-galactosidase by hosts transformed by recombinant DNA methods
WO1995007088A1 (en) * 1993-09-08 1995-03-16 New York Blood Center, Inc. RECOMBINANT α-GALACTOSIDASE ENZYME AND cDNA ENCODING SAID ENZYME

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
EDWARDS M ET AL: "CONTROL OF MANNOSE TO GALACTOSE RATIO DURING GALACTOMANNAN FORMATION IN DEVELOPING LEGUME SEEDS", PLANTA (HEIDELB), 187 (1). 1992. 67-74., XP000654833 *
OVERBEEKE N ET AL: "CLONING AND NUCLEOTIDE SEQUENCE OF THE ALPHA-GALACTOSIDASE CDNA FROM CYAMOPSIS TETRAGONOLOBA (GUAR)", PLANT MOLECULAR BIOLOGY, vol. 13, no. 5, 1 November 1989 (1989-11-01), pages 541 - 550, XP000095140 *
PROUDFOOT A E I ET AL: "PURIFICATION, CDNA CLONING AND HETEROLOGOUS EXPRESSION OF HUMAN PHOSPHOMANNOSE ISOMERASE", EUROPEAN JOURNAL OF BIOCHEMISTRY, vol. 219, 1994, pages 415 - 423, XP000652337 *
SMITH D J ET AL: "CLONING AND HETEROLOGOUS EXPRESSION OF THE CANDIDA ALBICANS GENE PMI 1 ENCODING PHOSPHOMANNOSE ISOMERASE", YEAST, vol. 11, 1995, pages 301 - 310, XP000655073 *

Also Published As

Publication number Publication date
WO1997020937A2 (en) 1997-06-12
GB9524752D0 (en) 1996-02-07
EP0866869A2 (en) 1998-09-30
JP2000502252A (en) 2000-02-29
CN1207772A (en) 1999-02-10
AU1193997A (en) 1997-06-27
MX9804483A (en) 1998-09-30
BR9612773A (en) 2001-01-02

Similar Documents

Publication Publication Date Title
AU7062496A (en) Process for the production of Bis(silyalkyl)-disulfanes
AU6242096A (en) Method of producing sustained-release preparation
EP0758028A3 (en) Process of producing graphite fiber
AU7693396A (en) Poly(9,9'-spiro-bisfluorenes), the production and use of same
AU5579996A (en) Decorative formation of tissue
AU6513096A (en) Treatment of fabrics
AU4716296A (en) Process for producing thietanones
CA2211314A1 (en) A process for preparing certain aza cyclohexapeptides
AU6132796A (en) Chemical compounds and methods of production thereof
AUPN089295A0 (en) Treatment of diabetic neuropathy
AU4329396A (en) Use of 3,4-diphenylchromans
WO1997020937A3 (en) Modification process
AU6328696A (en) Treatment of hemoglobinopathies
AU1369797A (en) Solid peroxo compounds and peroxy compounds stabilised by coating
AU691390B2 (en) Process for producing N-arylhydroxylamines and N-hetarylhydroxylamines
GB9406812D0 (en) Process of producing 8A- and 9A-azalide antibiotics
AU6056890A (en) Method of producing d-pantolactone
AU7623694A (en) Method of producing liquor
AU7542896A (en) Production of pigments
AU5839596A (en) Production of pigments
AU4729396A (en) Process for the preparation of 1,2-benzisothiazolin-3-ones
AU5486396A (en) Process for the preparation of spiroindolines
AU6829696A (en) Treatment of solutions
AUPN658795A0 (en) Method of producing alpha 2, 3 sialyltransferase
AU6556896A (en) Process for the production of carthamin

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 96199781.8

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG

WR Later publication of a revised version of an international search report
ENP Entry into the national phase

Ref document number: 1997 521002

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PA/a/1998/004483

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1996943105

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1996943105

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1996943105

Country of ref document: EP